betaine has been researched along with Hyperlipemia in 5 studies
glycine betaine : The amino acid betaine derived from glycine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "BET supplementation may be effective in preventing hyperlipidemia, disturbed NO availability, oxidative stress, and the development of fatty liver and atherosclerotic lesions that might result from excess amounts of cholesterol and methionine in the diet." | 7.88 | Effects of betaine supplementation on nitric oxide metabolism, atherosclerotic parameters, and fatty liver in guinea pigs fed a high cholesterol plus methionine diet. ( Bekpınar, S; Çevik, A; Genc, S; Gürdöl, F; Küskü-Kiraz, Z; Olgaç, V; Ünlücerci, Y; Uysal, M, 2018) |
| "BET supplementation may be effective in preventing hyperlipidemia, disturbed NO availability, oxidative stress, and the development of fatty liver and atherosclerotic lesions that might result from excess amounts of cholesterol and methionine in the diet." | 3.88 | Effects of betaine supplementation on nitric oxide metabolism, atherosclerotic parameters, and fatty liver in guinea pigs fed a high cholesterol plus methionine diet. ( Bekpınar, S; Çevik, A; Genc, S; Gürdöl, F; Küskü-Kiraz, Z; Olgaç, V; Ünlücerci, Y; Uysal, M, 2018) |
| "High-dose niacin has versatile and substantial efficacy for the treatment of hyperlipidemias, but its utility is compromised by various side effects, the most serious of which is liver damage." | 3.70 | Co-administration of equimolar doses of betaine may alleviate the hepatotoxic risk associated with niacin therapy. ( McCarty, MF, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, T | 1 |
| Lu, R | 1 |
| Chen, Y | 1 |
| Yuan, Y | 1 |
| Song, S | 1 |
| Yan, K | 1 |
| Zha, Y | 1 |
| Zhuang, W | 1 |
| Cheng, Y | 1 |
| Liang, J | 1 |
| Küskü-Kiraz, Z | 1 |
| Genc, S | 1 |
| Bekpınar, S | 1 |
| Ünlücerci, Y | 1 |
| Çevik, A | 1 |
| Olgaç, V | 1 |
| Gürdöl, F | 1 |
| Uysal, M | 1 |
| Lever, M | 1 |
| George, PM | 1 |
| Slow, S | 1 |
| Elmslie, JL | 1 |
| Shand, BI | 1 |
| Scott, RS | 1 |
| Chambers, ST | 1 |
| Kliueva, NN | 1 |
| Kalashnikova, NM | 1 |
| Okunevich, IV | 1 |
| Sapronov, NS | 1 |
| McCarty, MF | 1 |
1 review available for betaine and Hyperlipemia
| Article | Year |
|---|---|
Fibrates plus betaine: a winning combination?
Topics: Betaine; Clofibric Acid; Drug Therapy, Combination; Humans; Hyperlipidemias; Hypolipidemic Agents; L | 2010 |
4 other studies available for betaine and Hyperlipemia
| Article | Year |
|---|---|
Hyperhomocysteinemia and dyslipidemia in point mutation G307S of cystathionine β-synthase-deficient rabbit generated using CRISPR/Cas9.
Topics: Animals; Betaine; Body Weight; CRISPR-Cas Systems; Cystathionine beta-Synthase; Disease Models, Anim | 2020 |
Effects of betaine supplementation on nitric oxide metabolism, atherosclerotic parameters, and fatty liver in guinea pigs fed a high cholesterol plus methionine diet.
Topics: Animals; Arginine; Atherosclerosis; Betaine; Cholesterol; Cholesterol, Dietary; Diet, High-Fat; Diet | 2018 |
[Hypolipidemic activity of trimethylglycine].
Topics: Animals; Anticholesteremic Agents; Betaine; Cholesterol; Guinea Pigs; Hyperlipidemias; Lipoproteins, | 2012 |
Co-administration of equimolar doses of betaine may alleviate the hepatotoxic risk associated with niacin therapy.
Topics: Animals; Betaine; Homocysteine; Hyperlipidemias; Liver; Niacin; Rats; S-Adenosylmethionine | 2000 |